ATXS   $12.58  0.64% Market Closed

Astria Therapeutics, Inc.
Total Cash 354.70M
totalCashPerShare 6.286
EBITDA
Total Debt 5.79M
quickRatio 21.671
currentRatio 21.865
Total Revenue
debtToEquity 1.668
Revenue/Share
ROA -0.20040001
ROE -0.3406
grossProfits
freeCashflow -40.59M
operatingCashflow -80.38M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 416.18M
forwardPE -6.706215
floatShares 31.27M
sharesOutstanding 56.43M
sharesShort 3.49M
sharesShortPriorMonth 3.82M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.00%
heldPercentInstitutions 1.01%
Short Ratio help_outline 7.85%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 4.584
Price To Book help_outline 2.59
earningsQuarterlyGrowth
netIncomeToCommon -93.24M
trailingEps -2.38%
forwardEps -1.77%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.42 3Q 2024
institutionsCount 154
lastUpdated Nov. 7, 2024, 5:16 a.m.